Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Francisco J. Caballero-Granado"'
Autor:
Javier Martín-Vivaldi, Julián Torre-Cisneros, José Luis Montero, Israel Grilo, Salvador Vergara-López, Manuel Romero-Gómez, Mercedes González-Serrano, Raúl J. Andrade, Javier Salmerón, Francisco J. Caballero-Granado, Manuela Aguilar-Guisado, Robin Rivera-Irigoin, José A. García-García, Juan Macías, José A. Girón-González, Juan A. Pineda
Publikováno v:
AIDS Research and Human Retroviruses. 22:1236-1241
We compared the incidence of and factors associated with hepatocellular carcinoma (HCC) among hepatitis C virus (HCV)-monoinfected subjects and human immunodeficiency virus (HIV)/HCV-coinfected individuals, both with decompensated cirrhosis. In a ret
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fab5bc8045d0369da5cf16ebf07bd19e
https://doi.org/10.1089/aid.2006.22.1236
https://doi.org/10.1089/aid.2006.22.1236
Autor:
Julián Torre-Cisneros, Jesús Gómez-Mateos, Ana Arizcorreta-Yarza, Mark Becker, Mercedes González-Serrano, Juan A. Pineda, José A. Mira, Francisco J. Caballero-Granado, Manuel E. Jiménez-Mejías, Juan Macías, José A. Girón-González, Alberto Terrón, Dolores Merino
Publikováno v:
Journal of Antimicrobial Chemotherapy. 58:140-146
Received 11 December 2005; returned 14 February 2006; revised 2 April 2006; accepted 4 May 2006Objectives:Todeterminetheincidenceofandriskfactorsforseverehepatotoxicityofnelfinavir-containingregimens among human immunodeficiency virus/hepatitis C vir
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40ce1d5a808d540020a6254c56a3a2c9
https://doi.org/10.1093/jac/dkl214
https://doi.org/10.1093/jac/dkl214
Autor:
Mercedes González-Serrano, Juan A. Pineda, Manuela Aguilar-Guisado, Julián Torre-Cisneros, Javier Salmerón, José Aguilar, José A. Girón-González, Fernando Díaz-García, José A. García-García, José Luis Montero, J.M. Navarro, Francisco J. Caballero-Granado, Manuel Romero-Gómez, Raúl J. Andrade
Publikováno v:
Hepatology (Baltimore, Md.). 41(4)
The impact of human immunodeficiency virus (HIV) coinfection on the survival of patients with hepatitis C virus (HCV)-related end-stage liver disease (ESLD) is unknown. Because HIV infection is no longer considered an absolute contraindication for li
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab2355c28a47dcb3bff90a2ae08cc55d
https://pubmed.ncbi.nlm.nih.gov/16025502
https://pubmed.ncbi.nlm.nih.gov/16025502
Autor:
José A. Mira, Juan Macías, José A. Girón-González, Dolores Merino, Mercedes González-Serrano, Manuel E. Jiménez-Mejías, Francisco J. Caballero-Granado, Julián Torre-Cisneros, Alberto Terrón, Mark I. Becker, Jesús Gómez-Mateos, Ana Arizcorreta-Yarza, Juan A. Pineda
Publikováno v:
Journal of Antimicrobial Chemotherapy (JAC); Jul2006, Vol. 58 Issue 1, p140-146, 7p